AngioChem's Series C Round

AngioChem raised a round of funding on August 01, 2018.

AngioChem is a clinical-stage biotechnology discovering and developing new breakthrough drugs that are capable of crossing the blood-brain barrier to treat brain diseases. The company's EPiC platform …

Articles about AngioChem's Series C Round: